SWKS heads into the week after earnings with short sellers rebuilding aggressively and virtually every analyst on the Street trimming their price targets on the same morning.
The analyst response to Tuesday's results was swift and nearly uniform in direction. Six firms updated their views on July 29 alone — and five of them cut targets. Citigroup dropped its target most aggressively, from $77 to $64, now sitting almost exactly at the current price of $64.68. RBC Capital fell from $80 to $70, Stifel from $75 to $70, and TD Cowen from $75 to $65. Only UBS bucked the trend, nudging its target up from $65 to $70 while keeping a Neutral rating. Mizuho held its Underperform and cut to $52 — the most bearish target on the board. The consensus remains firmly at Hold, with 19 of 20 rated analysts at Hold or below and a mean target of $69.06, implying thin upside of roughly 7% from current levels. This is not a Street in disagreement about direction; it is a Street marking down expectations together.
Short positioning has been building in lockstep with that analyst caution. Short interest jumped 12% across the past week to reach 22.9% of free float — roughly 34 million shares — after a sharp step-up on July 23 that added more than 3.5 million shares in a single day. Over the past month, the short interest has grown nearly 24%. The ORTEX short score has climbed with it, reaching 71.8, near its highest reading of the past two weeks. Despite the scale of the short position, the borrow market remains notably undemanding: cost to borrow is running below 1%, and availability at 93.8% means there are roughly as many shares still available to lend as are currently borrowed. Days-to-cover sits at 6.5 days per FINRA's most recent fortnightly settlement. The picture is one of a crowded short that has not yet become a difficult or expensive one.
The bull and bear cases have been clearly defined by the pending Qorvo merger. Bulls point to multi-generational RF design wins, an expected 10%-plus CAGR in non-handset markets post-merger, and a valuation that looks genuinely cheap — the stock trades at roughly 12.7x trailing earnings and under 10x EV/EBITDA, with ORTEX scoring EV/EBIT in the 83rd percentile across the universe. Bears, however, cite Apple content headwinds, heavy smartphone concentration risk, and the geopolitical uncertainty hanging over Chinese regulatory approval of the QRVO deal. Factor scores reinforce the concern: EPS momentum ranks in just the 22nd percentile on a 30-day basis and the 33rd percentile over 90 days, even as the 12-month forward EPS growth score ranks in the 94th percentile — a sign the recovery thesis is real but has not yet translated into near-term estimate momentum.
SWKS has been a relative outperformer this week compared with most of its semiconductor peers. Closest peer QRVO moved in tandem, up 3.2% on the week, but the broader group has been hit hard — GFS fell 17.5%, NVTS dropped 22%, and SMTC lost 19%. That SWKS held its footing while peers crumbled suggests some degree of merger-premium support, or simply that the short base was already large enough to absorb incremental selling. Options positioning is mildly more cautious than usual — the put/call ratio at 0.57 is modestly above the 20-day mean of 0.52, with a z-score under 1 — pointing to hedging activity rather than outright fear.
The next earnings event is flagged for August 4. With the analyst community having just reset targets lower, the short position near a one-month high, and the Qorvo merger timeline unresolved, that date becomes the clearest near-term test of whether the Street's marks are conservative enough — or not yet conservative enough.
See the live data behind this article on ORTEX.
Open SWKS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
